Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Critical Care Medicine|January 19, 2024
Timely Cessation of Proton Pump Inhibitors in Critically Ill Patients Impacts Morbidity and Mortality: A Propensity Score-Matched Cohort StudyLars Palmowski, Alexander von Busch, Matthias Unterberg, et al.
Journal of Neurology|February 21, 2023
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: long-term results from COSMOSAlfonso Fasano, Rocío García-Ramos, Tanya Gurevich, et al.
Clinical Parkinsonism & Related Disorders|January 6, 2026
Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individualsYi Rang Han, Anna Jeong, Kanwal Ayub, et al.
Plos One|May 30, 2019
A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genesCaroline Holtkamp, Björn Koos, Matthias Unterberg, et al.
Herz|August 28, 2009
[Anesthesia with transfemoral and transapical aortic valve implantation. Periinterventional management and hemodynamic observations]Lars Bergmann, Eva Kottenberg, Torsten Heine, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 29, 2020
Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson's disease: results of the Italian GLORIA patient populationAngelo Antonini, Pietro Marano, Graziano Gusmaroli, et al.
Cells|March 6, 2021
The <i>NFKB1</i> Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on CMV Prophylaxis RegimensHartmuth Nowak, Svenja Vornweg, Katharina Rump, et al.
Parkinson'S Disease|February 28, 2020
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of LevodopaCindy Zadikoff, Werner Poewe, James T Boyd, et al.
Advances in Therapy|March 5, 2022
Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson's DiseaseAvner Thaler, Yael Barer, Ruth Gross, et al.
Journal of Neurology|December 29, 2010
Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled studyHeike Benes, Wolfgang Mattern, Ines Peglau, et al.
Pageof 9